Cpf1-based DNA in-vitro splicing method
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CAS CENT FOR EXCELLENCE IN MOLECULAR PLANT SCI
- Publication Date
- 2018-04-06
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology, in particular, the invention relates to a Cpf1-based DNA splicing method in vitro. The method of the invention can generate predetermined sticky ends, and can be used for DNA seamless splicing in vitro. Background technique
[0002] In 2010, J. Craig Venter's laboratory completed the artificial construction of Mycoplasma mycoides "Synthia", setting off a storm of synthetic biology research. Compared with the traditional restriction endonuclease digestion-ligase ligation cloning method, seamless splicing has many advantages such as convenient design and good compatibility because it does not introduce additional sequences, and it plays an increasingly important role in the development of synthetic biology. role.
[0003] The existing seamless splicing technologies mainly include splicing methods based on Type IIS restriction endonucleases, splicing methods based on specific base modifications, and s...